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Abstract
Background: We aimed to explore the effects of polypharmacy and specific drug classes on readmissions and
mortality after hip surgery.
Methods: We analyzed data on 272 consecutive hip fracture patients (72.1% females; age 82 ± 9 years) who
underwent acute hip replacement. We collected detailed data on the pharmacological treatment upon admission
and discharge. Patients were followed up over a period of 6 months after discharge using the Swedish National
Hospital Discharge Register and the Swedish National Cause of Death Register.
Results: After 6 months, 86 patients (31.6%) were readmitted, while 36 patients (13.2%) died. The total number of
medications upon discharge was predictive of rehospitalization (odds ratio (OR) 1.08, 95%CI 1.01–1.17, p = 0.030)
but not predictive of mortality. The use of antiosteoporotic agents (OR 1.86, 95%CI 1.06–3.26, p = 0.03), SSRIs (OR 1.90,
95%CI 1.06–3.42, p = 0.03), and eye drops (OR 4.12, 95%CI 1.89–8.97, p = 0.0004) were predictive of rehospitalization.
Treatment with vitamin K antagonists (OR 4.29, 95%CI 1.19–15.39, p = 0.026), thiazides (OR 4.10, 95%CI 1.30–12.91,
p = 0.016), and tramadol (OR 2.84, 95%CI 1.17–6.90, p = 0.021) predicted readmissions due to a new fall/trauma.
Conclusions: The total number of medications, use of antiosteoporotic agents, SSRIs, and eye drops predicted
rehospitalization after hip fracture surgery, while use of vitamin K antagonists, thiazides, and tramadol was
associated with readmissions due to a traumatic fall.
Trial registration: Hip fractures and polypharmacy in the elderly. Stimulus Project for the Elderly 2009-2011 (Reg
no 2009-11-26). Swedish National Board of Health and Welfare.
Keywords: Hip fracture, Patient readmission, Mortality, Polypharmacy
Background
Hip fracture in the elderly, following the trend in popula-
tion aging in developed countries, is a common cause of
hospital admission [1–4]. The mean age of typical patients
with acute hip fracture is high, over 80 years [5], which
implies multiple comorbidities combined with polyphar-
macy [5–7]. It is estimated that patients who suffer hip
fracture take, on average, six different medications, which
have been identified as an independent risk factor for falls
in the elderly [8, 9]. Moreover, two thirds of these patients
take drugs that raise the fall risk [9]. In recent years, there
has been a growing interest in optimizing pharmacological
treatment in the elderly by introduction of systematic
medication surveys [10, 11], but their effects on post-
discharge complications are not universally agreed
[12, 13]. In parallel, relatively little is known how poly-
pharmacy and treatment with specific drug classes impact
readmission rate and short-term mortality after hip frac-
ture surgery. Accordingly, the aim of this study was to
explore the potential association of discharge medications
with the postoperative readmission and death rate.
Methods
Patients
Between November 2009 and June 2011, we enrolled
304 consecutive patients who were admitted to the De-
partment of Orthopaedics at Skåne University Hospital
in Malmö, Sweden, with a preliminary diagnosis of hip
fracture. Of these, we excluded 32 patients: 23 who did
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not meet criteria for hip fracture (International Classifi-
cation of Diseases, 10th Revision (ICD-10) code S72.0-2)
i.e., without confirmed fracture during secondary assess-
ment or with a fracture present in another location; 4
who did not undergo surgery; 3 who underwent surgery
at another hospital; and 2 for whom the complete data-
set was not available. The remaining 272 patients ac-
cepted participation in the study.
Methods
Patient characteristics were recorded after admission in-
cluding biometric and routine basic clinical data (blood
pressure, plasma concentrations of sodium, potassium,
creatinine, and hemoglobin), information about current
medications, and their indications plus American Society
of Anesthesiologists (ASA) Classification of Physical
Health grade [14] assessed before hip surgery. In the
next stage, two clinical pharmacists contracted for the
project and retrieved the actual medication list from
the Swedish National Pharmaceutical Register, which
holds records of all prescribed drugs with their dispens-
ing dates for all Swedish citizens. The patient’s family,
other caregivers, or general practitioner verified the
medication list, if necessary. Drugs were classified
according to the Anatomical Therapeutic Chemical
(ATC) classification system [15], in which the active
substances are divided into 14 different groups accord-
ing to the organ or system on which they act (1st level),
and their therapeutic, pharmacological, and chemical
properties (2nd–5th level).
The routine reassessment of the basic clinical parameters
(blood pressure, electrolytes, creatinine, and hemoglobin)
on the 3rd day after hip fracture surgery was performed,
and the corresponding data were recorded in the data-
base. Within the first postoperative week, a clinical
medication review based on a structured approach pre-
viously proposed [16] was performed by a pharmacist
and consultant physician in internal medicine (AF).
Dosages and indications were checked, unsuitable drugs
were withdrawn, and dosages were adjusted, if appro-
priate. Local (valid for Skåne region, southern Sweden),
national, and international guidelines constituted
grounds for decision-making, which was reached by
consensus between the pharmacist and physician. In se-
lected cases, the pharmacist and physician discussed
the relevance of indications with the orthopedic sur-
geon or the appropriate specialist. The patient’s general
practitioner received written information about alter-
ations, as did the patient or family. Patients were
followed up over a period of 6 months after discharge
from the hospital using a unique personal 10-digit iden-
tity number that can be linked to the Swedish National
Hospital Discharge Register and the Swedish National
Cause of Death Register.
The number and causes of readmissions and death sta-
tistics were retrieved from the available hospital records
in the study catchment area and appropriate national
registers. The emergency department visits that did not
result in hospital readmission were not included. The
reasons for the readmission were classified according to
the main diagnosis in the ICD-10 coding system. Specific
categories for readmission were defined as fall injury,
cardiac, neurological, psychiatric, surgical, and infection.
Statistical analyses
Patient characteristics were reported as mean and stand-
ard deviation or proportions as appropriate. Proportions
of specific drug use upon admission and their changes
after medication review were calculated. The total num-
ber and reasons for readmissions as well as mortality
within the first six months after discharge from hospital
were determined. The relations of total number and type
of discharge medications with readmission risk or death,
as the categorical dependent variables, respectively, were
assessed using a multivariable-adjusted (for age and
gender) logistic regression model. In a subsidiary ana-
lysis, only readmissions due to fall injury, infection, or
cardiovascular disease were assessed as a categorical
dependent variable. All analyses were performed using
IBM SPSS Statistics version 22 (SPSS Inc., Chicago, IL,
USA). All tests were two-sided whereby p < 0.05 was
considered statistically significant.
Results
Table 1 shows intervention group characteristics including
supine blood pressure, plasma concentrations of sodium,
potassium, creatinine, and hemoglobin recorded upon ad-
mission, and the routine reassessment of the same clinical
parameters on the 3rd day after hip fracture surgery.
Women were overrepresented (n = 196, 72.1%), and the
mean age was 82.0 ± 9.0 years, range from 53 to 100 years.
Medications upon admission and discharge
As can be seen in Table 1, upon admission to hospital pa-
tients in the intervention group had on average 6.2 +/− 3.9
prescribed drugs (range from 0 to 20), and the corre-
sponding number was 7.8 +/− 3.6 (range from 0 to 20)
upon discharge. Table 2 shows current medications, ac-
cording to ATC classification, upon arrival at hospital and
on discharge in the intervention group. The most com-
mon medications upon admission were platelet aggrega-
tion inhibitors, antihypertensive agents, and among these,
diuretics, beta-blocking agents, and agents acting on the
renin-angiotensin system, then, anxiolytics, and antide-
pressants. The most common medication to be removed
or modified during reviews was antihypertensive treat-
ment, discontinued totally in 31 patients. Among the anti-
hypertensive agents, diuretics were discontinued in 39
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patients, whereas calcium channel blockers were ceased in
24 patients. Further, there were only slight reductions in
the use of beta-blocking agents, hypnotics, sedatives, and
antidepressants. There were no changes made in treat-
ment with dopaminergic agents, drugs for obstructive air-
way diseases, and eye drops. In contrast, low-molecular
weight heparin (LMWH, n = 89), tramadol (n = 147), and
paracetamol (n = 157) were frequently initiated during
hospital stay and prescribed at discharge, whereas anti-
osteoporotic drugs were initiated in 15 patients during
hospital stay.
In summary, upon discharge, the most common medi-
cation groups were analgesics, antihypertensive agents,
LMWH, antiosteoporotic agents, platelet aggregation in-
hibitors, and antidepressants.
Readmissions
During the 6-month follow-up period, 86 patients (31.6%)
were readmitted. In total, there were 120 readmissions,
and the most common cause of readmission was a new
fall/trauma (n = 31), followed by infection (n = 27). The
total number of medications upon discharge was predictive
of rehospitalization (OR 1.08, 95%CI 1.01–1.17, p = 0.030)
as also was plasma potassium on 3rd day post-surgery (OR
per one mmol/L 2.74, 95%CI 1.50–5.00, p = 0.001), espe-
cially in regard to readmission due to a new cardiovascular
event (OR 3.36, 95%CI 1.18–9.57, p = 0.023), or infection
(OR 3.04, 95%CI 1.06–8.71, p = 0.039).
In specific therapeutic groups (see Fig. 1), drugs affect-
ing bone structure and mineralization (=antiosteoporotic
agents; OR 1.86, 95%CI 1.06–3.26, p = 0.03), SSRIs (OR
1.90, 95%CI 1.06–3.42, p = 0.03), and eye drops (OR
4.12, 95%CI 1.89–8.97, p = 0.0004) were all predictive of
rehospitalization. Further, treatment with eye drops was
predictive of fall injury (OR 5.97, 95%CI 2.48–14.33, p =
0.00007), as also was treatment with antiosteoporotic
agents (OR 2.93, 95%CI 1.34–6.41, p = 0.007). In con-
trast, increased risk of readmission due to infection was
associated with SSRI (OR 3.40, 95%CI 1.30–8.88, p =
0.013). Other medications associated with increased re-
admission risk due to a new fall/trauma were vitamin K
antagonists (VKA, OR 4.29, 95%CI 1.19–15.39, p =
0.026), thiazides (OR 4.10, 95%CI 1.30–12.91, p = 0.016),
and tramadol (OR 2.84, 95%CI 1.17–6.90, p = 0.021). As-
sociation between eye drops and fall injury was inde-
pendent of beta-blocker use as also was association
between thiazides and fall injury in regard to plasma
electrolytes including potassium.
Mortality
Thirty-six of the 272 patients (13.2%) died within
6 months after hip surgery. The number of medications
did not predict mortality (OR 0.97, 95%CI 0.88–1.07,
p = 0.55). As shown in Fig. 2, the 6-month mortality
was inversely associated with paracetamol treatment
upon discharge (OR 0.28, 95%CI 0.13–0.62, p = 0.001),
Table 1 Clinical characteristics of study population (n = 272)
Parameter Mean/proportion Std. deviation Minimum Maximum
Age, years 82.0 9.0 53 100
Gender, n, % females 196
72.1
P-Glucose admission, mmol/L 7.5 2.1 3.4 19.8
P-Glucose, 3rd day, mmol/L 9.0 3.2 5.7 16.9
P-Sodium admission, mmol/L 138.7 3.4 125.0 147.0
P-Sodium 3rd day, mmol/L 137.0 3.5 120.0 146.0
P-Potassium admission, mmol/L 3.9 0.5 2.6 5.9
P-Potassium 3rd day, mmol/L 3.7 0.5 2.4 5.5
P-Creatinine admission, μmol/L 88.5 48.6 26.0 563.0
P-Creatinine 3rd day, μmol/L 91.2 67.4 34.0 614.0
P-Hemoglobin admission, g/L 122.7 15.7 74.0 192.0
P-Hemoglobin 3rd day, g/L 106.2 13.1 72.0 143.0
Blood pressure-systolic admission, mmHg 144 22 90 220
Blood pressure-systolic 3rd day, mmHg 121 18 70 180
Blood pressure-diastolic admission, mmHg 75 12 50 120
Blood pressure-diastolic 3rd day, mmHg 63 10 40 100
No. of medications, admission 6.2 3.9 0.0 20.0
No. of medications, discharge 7.8 3.6 0.0 20.0
Glucose, sodium, potassium, and creatinine were plasma levels
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Table 2 Prevalent medications (ATC) upon admission and discharge after hip fracture surgery (n = 272)
ATC-code medication Admission (n) Discharge (n) Difference (n)
A02B drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) 79 82 −3
B01AA vitamin K antagonists 13 12 −1
B01AB heparin group 1 90 +89
B01AC platelet aggregation inhibitors 108 89 −19
C01D vasodilators, (nitrates) 34 40 +6
C03 diuretics, all 113 66 −47
C03A low-ceiling diuretics (thiazides) 35 17 −18
C03C high ceiling diuretics (loop) 72 37 −35
C03D potassium-sparing agents (C03DA, aldosterone antagonists) 31 11 −20
C07A beta-blocking agents 85 84 −1
C08C-D calcium channel blockers 55 31 −24
C09A-C agents acting on the renin-angiotensin system 72 62 −10
C01-09 antihypertensives 179 148 −31




N02AX opioids weak (tramadol) 13 160 +147
N02B other analgesics (incl. paracetamol) 63 220 +157
N04B dopaminergic agents (antiparkinson) 15 15 +/−0
N05B anxiolytics (incl. benzodiazepines) 56 48 −8
N05C hypnotics and sedatives (incl. zolpidem and heminevrin) 80 78 −2
N06A antidepressants, totally 80 79 −1
N06AB SSRI only 66 63 −3
N06D psychoanaleptics (antidementia) 15 14 −1
R03A-B drugs for obstructive airway diseases 28 28 +/−0
S01E-X ophtalmologicals (eye drops) 31 31 +/−0
Fig. 1 The relative risk of readmission (86/272) within 6 month after acute hip fracture surgery as indicated by specific medication classes upon
discharge from hospital in a multivariable-adjusted (for age and gender) logistic regression model
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while there was a tendency for higher mortality among
patients treated with strong opioids such as morphine
(OR 2.26, 95%CI 0.95–5.39, p = 0.065). However, when
entered in the same model, the presence of strong
opioids in the absence of paracetamol was a significant
predictor of mortality (OR 2.95, 95%CI 1.19–7.34, p =
0.020), independently of prevalent malignant disease
(data not shown).
Discussion
In this study, we have shown that the number of medi-
cations upon discharge is predictive of readmission but
not death within six months after acute hip fracture
surgery. Further, patients treated with antiosteoporotic
agents, SSRI, and eye drops have increased overall risk
of readmission, whereas use of vitamin K antagonists,
thiazides, and tramadol is associated with increased risk
of readmission due to fall injury. Finally, increased mor-
tality may be indicated by a sole opioid use at discharge.
The medication reviews performed in our cohort re-
vealed a considerable number of pharmacological issues
that received attention and were resolved, if found
appropriate.
Zermansky et al. [17] found consultations with a clin-
ical pharmacist to be effective in care home residents, a
study population with mainly the same characteristics as
a group with hip fractures. From a practical point of
view, this concept worked well in our study; the pharma-
cist started by interviewing the patient and scrutinized
different data sources to complete the medication list. A
form was filled in, structuring the review, and the result
was presented to the internal medicine consultant who
decided by consensus, which changes would be suitable
and safe.
Notable was that a new trauma or fall injury were the
most common reasons for new contact with the hospital.
Prevention of falls, better information regarding the hip
fracture, and improvement of rehabilitation seem wise,
together with improvement in primary care.
Relationships between discharge medications and
post-discharge complications deserve specific comments.
The use of eye drops was the strongest single predictor
of readmission including new trauma. We suggest that
the visual impairment is the decisive factor underlying
fall injury, and that this group, although not large in
number, should receive more specific care, for instance,
through adjustments made in their home environment.
Another possible explanation of this observation is in-
duction of bradyarrhythmia by beta-blocking component
of eye drops; however, there was no significant inter-
action between eye drops and beta-blockers.
The association between antiosteoporotic drugs and
readmissions due to a new fall injury is more obvious
as the elderly with osteoporosis have double the risk of
falling compared with those without osteoporosis, not
only due to osteoporosis but also due to other shared
risk factors such as weight loss, small muscle mass, low
muscle strength, low physical exercise levels, and lim-
ited mobility [18]. Moreover, low BMI is a factor associ-
ated with higher prevalence of orthostatic hypotension
[19]. The use of SSRI was particularly predictive of
readmissions due to infectious disease. Of these, the
Fig. 2 The relative mortality (36/272) within 6 month after acute hip fracture surgery as indicated by specific medication classes upon discharge
from hospital in a multivariable-adjusted (for age and gender) logistic regression model. PPI proton pump inhibitor, VKA vitamin K antagonist,
LMWH low-molecular weight heparin, CCB calcium channel blocker, RAA renin-angiotensin aldosterone, SSRI selective serotonin reuptake inhibitors
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two most frequent causes are urinary infection and
pneumonia. SSRIs have been reported to cause urinary
retention [20] and negatively influence renal and re-
spiratory function in the post-operative period [21].
Moreover, SSRIs are associated with increased risk of
falls and confusion as possible contributory factors
[22]. The role of VKA in the elevated risk of readmis-
sion after fall injury can be explained by medical vigi-
lance when dealing with patients who demonstrate
higher probability of occult bleeding, and thus require
prompt diagnosis including radiology, laboratory as-
sessment, and extended observation. A fourfold in-
creased risk of readmission due to a new fall injury was
associated with thiazides, and not other types of antihy-
pertensive drugs, is remarkable. However, regardless of
antihypertensive effect, thiazide diuretics may also be
involved in intravascular volume reduction and electro-
lytic disorders, all of which contribute to the increased
risk of falls [23]. These results question the use of thia-
zide diuretics in elderly and frail patients and suggest
the use of other types of antihypertensive drugs, or
simply discontinuation of treatment. In parallel, our re-
sults question the prolonged use of tramadol in the
post-discharge period, as this pharmacological agent,
routinely used for the post-operative pain alleviation,
was associated with almost threefold increased risk of a
new trauma, most probably due to confusion, which is
a well-known complication related to this drug [24].
Finally, patients treated, on discharge, with morphine
only demonstrated the highest mortality, whereas those
taking paracetamol demonstrated lower mortality. This
observation is logical as it reflects the overall status of
patient. In general, chronic and severe pain, which re-
quires permanent opioid treatment, indicates advanced
disease with poor prognosis, whereas the use of weak
analgesics indicates a more benign disease course.
The reason that patients had in general more medica-
tions upon discharge than admission despite the medica-
tion optimization is related to the need for post-operative
pain reduction (analgesics) as well as thrombosis prophy-
laxis (LMWH), both of which are routinely started at
hospital and continued at discharge.
Study strengths and limitations
Our catchment area is served by one university hospital,
and all hip fractures were treated at the same study site.
The hospital medical records were accessible and scruti-
nized by the researchers. Moreover, the Swedish record
system is particularly appropriate for a study of this nature
as the coverage of events of interest has high efficacy and
validity. However, medical records from primary care were
not available; thus, primary care physicians may have in-
troduced some post-discharge changes in medications that
were unnoticed by the authors.
Conclusions
The total number of medications and use of specific
drug classes are associated with increase readmission
risk after acute hip fracture surgery in older patients.
Medication reviews and withdrawal or modification of
drugs may be justified in post-operative period as several
drug-related problems were identified. Further studies,
including randomized controlled trials on medication
optimization, are needed.
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